WPA
XRAY icon

West Paces Advisors’s Dentsply Sirona XRAY Stock Holding History

West Paces Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22
Closed -$783 – 667
2023
Q4 		$783 Buy
+22
New +$698 ﹤0.01% 522
2022
Q3 		– Sell
-14
Closed -$500 – 587
2022
Q2 		$500 Buy
+14
New +$566 ﹤0.01% 557
2019
Q4 		– Sell
-13
Closed -$693 – 499
2019
Q3 		$693 Buy
+13
New +$698 ﹤0.01% 475
2018
Q1 		– Sell
-30
Closed -$1.98K – 467
2017
Q4 		$1.98K Sell
30
-33
-52% -$2.1K ﹤0.01% 437
2017
Q3 		$3.77K Hold
63
– – ﹤0.01% 404
2017
Q2 		$4.08K Hold
63
– – ﹤0.01% 403
2017
Q1 		$3.93K Buy
63
+19
+43% +$1.14K ﹤0.01% 407
2016
Q4 		$2.54K Buy
+44
New +$2.6K ﹤0.01% 461

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

West Paces Advisors's XRAY Position: Q1 2024 in Review

West Paces Advisors sold out of Dentsply Sirona (XRAY) in Q1 2024, closing a stake of 22 shares — an estimated $783 sold.

West Paces Advisors first reported a position in XRAY in Q4 2016 and held it in 8 quarters. The position peaked at $4.08K in Q2 2017. 450 funds tracked by Wall St. Rank hold XRAY as of Q1 2024.

  • West Paces Advisors reported no remaining Dentsply Sirona position as of Q1 2024 after selling out during the quarter.
  • West Paces Advisors sold 22 Dentsply Sirona shares in Q1 2024, an estimated $783.
  • West Paces Advisors first reported a position in Dentsply Sirona in Q4 2016 and held it in 8 quarters.
  • West Paces Advisors's Dentsply Sirona position peaked at $4.08K in Q2 2017.
  • 450 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2024.

Based on West Paces Advisors's 13F filing for Q1 2024, filed 15 Apr 2024.